Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury

Abstract

The objective was to compare test characteristics of a single serum concentration of glial fibrillary acidic protein (GFAP), S‐100β, and ubiquitin carboxyl terminal hydrolase L1 (UCH‐L1), obtained within 6 hours of head injury, to diagnose mild traumatic brain injury (mTBI) in head‐injured subjects.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: May 18, 2017
• Source ID: 10.1111/acem.13174

Entities

People

• Derek T. Schloemann
• Jeffrey J Bazarian
• Lawrence M. Lewis
• Linda Papa
• Miranda Lindburg
• Robert D. Welch
• Robert P. Fucetola

Organizations

• Orlando Regional Medical Center
• United States Army Medical Research and Development Command
• University of Rochester
• Washington University in St. Louis
• Wayne State University

Tags

Fields of Study

• Medicine

Readers

• Neuroscience
• Oncology and Biomarker-Based Cancer Detection.
• Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.